Patients with treatment-refractory Mycobacterium avium complex (MAC) lung disease who received amikacin liposome inhalation suspension and guideline therapy had increased culture conversion compared with guideline therapy alone.
Patient-directed prone positioning is not feasible in spontaneously breathing, nonintubated patients hospitalized with COVID-19.
Patients with bronchiectasis on long term macrolide therapy were at low risk of developing macrolide-resistant Mycobacterium avium complex (MAC) disease.
An existing virtual transition and recovery program for patients with sepsis may be used as a model for similar programs for COVID-19 survivors.
High levels of anxiety are a risk factor for loss of asthma control and decline in disease-related quality of life.
Critically ill patients with COVID-19 who experience concurrent pulmonary embolism do not have increased mortality compared with patients without pulmonary embolism.
In older adults coming to the emergency department with COVID-19, delirium was common and often presented without other typical symptoms or signs.
Lung transplant recipients who were given antifungal medications prophylactically to prevent invasive fungal infections had lower rates of mortality.
Patients with severe COVID-19 pneumonia had improved prognosis after receiving a short course of methyl-prednisolone pulses during the second week of disease.
Systemic complement activation is associated with respiratory failure in patients with coronavirus disease 2019.
